EDIT:NASDAQ
Editas Medicine Inc
$2.17
arrow_upward
+1.40%(+0.030) 1D
$2.18
arrow_upward
+0.46% (+0.0100)todayPre-market
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.14
High
$2.21
Low
$2.01
Mkt. cap
334.92M
Avg. vol.
2.42M
Volume
2.93K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.14
High
$2.21
Low
$2.01
Mkt. cap
334.92M
Avg. vol.
2.42M
Volume
2.93K
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
Reuters
·
1 hour ago
S&P 500, Nasdaq futures slide as Nvidia earnings, Anthropic debut loom
Business Insider
·
1 hour ago
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Investing.com
·
3 hours ago
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
Traders Union
·
1 hour ago
S&P 500 remained close to all-time highs after Nasdaq's drop, Dario Perkins notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com